| Primary |
| Hypertension |
36.7% |
| Product Used For Unknown Indication |
24.9% |
| Drug Use For Unknown Indication |
6.3% |
| Atrial Fibrillation |
5.2% |
| Blood Pressure Increased |
4.2% |
| Type 2 Diabetes Mellitus |
2.9% |
| Diabetes Mellitus |
2.3% |
| Blood Pressure |
1.8% |
| Depression |
1.8% |
| Cardiovascular Disorder |
1.6% |
| Cardiac Disorder |
1.5% |
| Prophylaxis |
1.5% |
| Angina Pectoris |
1.3% |
| Arrhythmia |
1.3% |
| Coronary Artery Disease |
1.3% |
| Suicide Attempt |
1.2% |
| Cardiac Failure |
1.2% |
| Heart Rate Increased |
1.1% |
| Blood Cholesterol |
1.0% |
| Essential Hypertension |
1.0% |
|
| Completed Suicide |
13.2% |
| Syncope |
13.2% |
| Bradycardia |
10.3% |
| Hypotension |
8.6% |
| Blood Pressure Increased |
4.7% |
| Ventricular Tachycardia |
4.4% |
| Medication Error |
4.2% |
| Product Substitution Issue |
4.2% |
| Suicidal Ideation |
4.2% |
| Dizziness |
4.1% |
| Palpitations |
3.7% |
| Pharmaceutical Product Complaint |
3.4% |
| Drug Ineffective |
3.1% |
| Product Quality Issue |
2.9% |
| Toxicity To Various Agents |
2.9% |
| Therapeutic Response Unexpected With Drug Substitution |
2.7% |
| Death |
2.5% |
| Hypertension |
2.5% |
| Vomiting |
2.5% |
| Intentional Drug Misuse |
2.4% |
|
| Secondary |
| Hypertension |
24.6% |
| Product Used For Unknown Indication |
24.5% |
| Drug Use For Unknown Indication |
15.5% |
| Atrial Fibrillation |
4.5% |
| Diabetes Mellitus |
3.2% |
| Depression |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Cardiac Disorder |
2.7% |
| Pain |
2.6% |
| Blood Pressure Increased |
2.1% |
| Angina Pectoris |
2.1% |
| Suicide Attempt |
2.0% |
| Blood Pressure |
1.8% |
| Thyroid Disorder |
1.5% |
| Blood Pressure Abnormal |
1.5% |
| Cardiac Failure |
1.3% |
| Thrombosis Prophylaxis |
1.2% |
| Anxiety |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Intentional Overdose |
1.1% |
|
| Completed Suicide |
17.6% |
| Hypotension |
10.8% |
| Syncope |
7.8% |
| Drug Ineffective |
5.7% |
| Somnolence |
4.7% |
| Bradycardia |
4.5% |
| Respiratory Arrest |
4.0% |
| Death |
3.9% |
| Suicide Attempt |
3.9% |
| Angina Pectoris |
3.7% |
| Vomiting |
3.7% |
| Suicidal Ideation |
3.6% |
| Poisoning |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Dizziness |
3.2% |
| Medication Error |
3.2% |
| Myocardial Infarction |
3.2% |
| Nausea |
3.2% |
| Tremor |
3.2% |
| Weight Decreased |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.2% |
| Drug Use For Unknown Indication |
21.3% |
| Hypertension |
12.8% |
| Atrial Fibrillation |
4.0% |
| Pain |
3.2% |
| Diabetes Mellitus |
3.1% |
| Rheumatoid Arthritis |
2.8% |
| Blood Cholesterol Increased |
2.6% |
| Prophylaxis |
2.2% |
| Cardiac Disorder |
2.0% |
| Multiple Myeloma |
2.0% |
| Depression |
2.0% |
| Type 2 Diabetes Mellitus |
1.8% |
| Blood Pressure |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Osteoporosis |
1.4% |
| Coronary Artery Disease |
1.3% |
| Nuclear Magnetic Resonance Imaging |
1.2% |
| Anxiety |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Vomiting |
12.6% |
| Weight Decreased |
8.2% |
| Myocardial Infarction |
6.7% |
| Flushing |
6.4% |
| Death |
6.2% |
| Nausea |
5.3% |
| Pain |
4.6% |
| Pneumonia |
4.5% |
| Dyspnoea |
4.3% |
| Weight Increased |
4.3% |
| Pruritus |
4.3% |
| Drug Ineffective |
4.2% |
| Urinary Tract Infection |
3.9% |
| Thrombocytopenia |
3.9% |
| Renal Failure Acute |
3.7% |
| Pyrexia |
3.5% |
| Rash |
3.4% |
| Syncope |
3.4% |
| Diarrhoea |
3.3% |
| Oedema Peripheral |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
18.9% |
| Hypertension |
16.7% |
| Coronary Artery Disease |
8.9% |
| Atrial Fibrillation |
6.4% |
| Dyslipidaemia |
6.0% |
| Insomnia |
6.0% |
| Depression |
4.6% |
| Type 2 Diabetes Mellitus |
4.6% |
| Tachycardia |
3.6% |
| Anxiety |
3.2% |
| Decreased Appetite |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Hyperlipidaemia |
3.2% |
| Prophylaxis Against Hiv Infection |
2.8% |
| Arrhythmia |
1.4% |
| Asthma |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Blood Pressure |
1.4% |
| Bone Disorder |
1.4% |
| Cardiac Failure |
1.4% |
|
| Drug Interaction |
30.7% |
| Glycosylated Haemoglobin Increased |
5.3% |
| Renal Failure Acute |
5.3% |
| Torsade De Pointes |
5.3% |
| Alcohol Interaction |
4.0% |
| Hyponatraemia |
4.0% |
| Hypotension |
4.0% |
| Sedation |
4.0% |
| Syncope |
4.0% |
| Transaminases Increased |
4.0% |
| Ventricular Tachycardia |
4.0% |
| Weight Increased |
4.0% |
| Asthma |
2.7% |
| Atrioventricular Block Complete |
2.7% |
| Cognitive Disorder |
2.7% |
| Headache |
2.7% |
| Hepatic Enzyme Increased |
2.7% |
| Hypertension |
2.7% |
| Potentiating Drug Interaction |
2.7% |
| Shock |
2.7% |
|
